Brief: Conmed Q3 Income From Operations USD 30.3 Million
25/10/2023 21:05
Oct 25 (Reuters) - Conmed Q3 EPS USD 0.5. * Q3 pretax profit USD 20.281 million * Q3 net income USD 15.837 million * Q3 sales USD 304.578 million vs. IBES estimate USD 300.9 million * outlook FY revenue USD 1,240-1,260 million * outlook FY adjusted EPS USD 3.45-3.55
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED